AMYCO: evaluation of mutational impact on prion-like proteins aggregation propensity

BackgroundAround 1% of human proteins are predicted to contain a disordered and low complexity prion-like domain (PrLD). Mutations in PrLDs have been shown promote a transition towards an aggregation-prone state in several diseases.ResultsRecently, we have shown that an algorithm that considers the effects of mutations on PrLDs composition, as well as on localized amyloid propensity can predict the impact of these amino acid changes on protein intracellular aggregation. In this application note, we implement this concept into the AMYCO web server, a refined algorithm that forecasts the influence of amino acid changes in prion-like proteins aggregation propensity better than state-of-the-art predictors.ConclusionsThe AMYCO web server allows for a fast and automated evaluation of the effect of mutations on the aggregation properties of prion-like proteins. This might uncover novel disease-linked amino acid changes in the sequences of human prion-like proteins. Additionally, it can find application in the in silico design of synthetic prion-like proteins with tuned aggregation propensities for different purposes. AMYCO does not require previous registration and is freely available to all users at: http://bioinf.uab.cat/amyco/.

[1]  Kacy R. Paul,et al.  Composition-based prediction and rational manipulation of prion-like domain recruitment to stress granules , 2020, Proceedings of the National Academy of Sciences.

[2]  Michael Benatar,et al.  Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.

[3]  S. Ventura,et al.  Computational analysis of candidate prion-like proteins in bacteria and their role , 2015, Front. Microbiol..

[4]  D. Cleveland,et al.  Prion-like spread of protein aggregates in neurodegeneration , 2012, The Journal of experimental medicine.

[5]  G. Di Guardo.  Commentary: A bacterial global regulator forms a prion , 2017, Front. Microbiol..

[6]  Salvador Ventura,et al.  The role of protein sequence and amino acid composition in amyloid formation: scrambling and backward reading of IAPP amyloid fibrils. , 2010, Journal of molecular biology.

[7]  Asa Ben-Hur,et al.  De novo design of synthetic prion domains , 2012, Proceedings of the National Academy of Sciences.

[8]  Oliver D. King,et al.  The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease , 2012, Brain Research.

[9]  B. Jeong,et al.  Novel Polymorphisms and Genetic Characteristics of the Prion Protein Gene (PRNP) in Dogs—A Resistant Animal of Prion Disease , 2020, International journal of molecular sciences.

[10]  Gregory A. Newby,et al.  Luminidependens (LD) is an Arabidopsis protein with prion behavior , 2016, Proceedings of the National Academy of Sciences.

[11]  The Uniprot Consortium,et al.  UniProt: a hub for protein information , 2014, Nucleic Acids Res..

[12]  B. Jeong,et al.  Identification of the novel polymorphisms and potential genetic features of the prion protein gene (PRNP) in horses, a prion disease-resistant animal , 2020, Scientific Reports.

[13]  María Martín,et al.  UniProt: A hub for protein information , 2015 .

[14]  X. Salvatella,et al.  hnRNPDL Phase Separation Is Regulated by Alternative Splicing and Disease-Causing Mutations Accelerate Its Aggregation , 2020, Cell reports.

[15]  Asa Ben-Hur,et al.  Amino acid composition predicts prion activity , 2017, PLoS Comput. Biol..

[16]  James A. Toombs,et al.  Compositional Determinants of Prion Formation in Yeast , 2009, Molecular and Cellular Biology.

[17]  S. Ventura,et al.  The Rho Termination Factor of Clostridium botulinum Contains a Prion-Like Domain with a Highly Amyloidogenic Core , 2016, Front. Microbiol..

[18]  Maria Rosario Fernández,et al.  Characterization of Amyloid Cores in Prion Domains , 2016, Scientific Reports.

[19]  Maria Rosario Fernández,et al.  Perfecting prediction of mutational impact on the aggregation propensity of the ALS‐associated hnRNPA2 prion‐like protein , 2017, FEBS letters.

[20]  L. Malinovska,et al.  Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation , 2015, Proceedings of the National Academy of Sciences.

[21]  Nicolas L. Fawzi,et al.  Mechanistic View of hnRNPA2 Low-Complexity Domain Structure, Interactions, and Phase Separation Altered by Mutation and Arginine Methylation. , 2018, Molecular cell.

[22]  Avinash M. Veerappa,et al.  Complex interaction between HNRNPD mutations and risk polymorphisms is associated with discordant Crohn’s disease in monozygotic twins , 2017, Autoimmunity.

[23]  Adriano Aguzzi,et al.  Prions: protein aggregation and infectious diseases. , 2009, Physiological reviews.

[24]  L. Kunkel,et al.  A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). , 2014, Human molecular genetics.

[25]  Joost Schymkowitz,et al.  What Makes a Protein Sequence a Prion? , 2015, PLoS Comput. Biol..

[26]  J. Taylor,et al.  Effects of Mutations on the Aggregation Propensity of the Human Prion-Like Protein hnRNPA2B1 , 2017, Molecular and Cellular Biology.

[27]  G. Braus,et al.  One Juliet and four Romeos: VeA and its methyltransferases , 2015, Front. Microbiol..

[28]  E. Ross,et al.  Generating new prions by targeted mutation or segment duplication , 2015, Proceedings of the National Academy of Sciences.

[29]  S. Radford,et al.  Using protein engineering to understand and modulate aggregation , 2020, Current opinion in structural biology.

[30]  Marco Y. Hein,et al.  A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation , 2015, Cell.